Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 1997

View Archived Issues

Betulinic acid derivatives reported to have anti-HIV activity

Pfizer claims glycogen phosphorylase inhibitors

Piperidine derivatives reported by Schering-Plough

AHP claims smooth muscle cell proliferation inhibitors

Merck & Co. continues to develop farnesyl protein transferase inhibitors

Aminoisoindole derivatives discovered for neuropsychological disorders

A new class of GABA receptor ligands claimed by Neurogen

Novel diabetes treatments reported by Shaman

Hoechst develops antipsychotic agents

Takeda's new cephems

1996 in review: Adcock Ingram

Antineoplastic antibiotics isolated by Japanese investigators

Hepatoprotective activity of Chinese medicine tested in animal models

Progenics awarded grants to develop HIV therapeutics

Demeter receives funding for anticancer program

Pharma Patch restructures

Patent coverage sought for novel approach to reducing side effects of vitamin A

Marnac licenses broad-spectrum antifibrotic drug

Pall Corporation finalizes acquisition

GelMed receives patent coverage for new use of polymers

Golden and Syncor sign letter of intent

Positive results reported from TOBI pivotal trials

Cytogen/Elan oral drug delivery collaboration advances

GeneMedicine IND approved

U.S. patent for Tularik drug discovery assays

Tularik receives patent coverage for protein involved in immune response

ICOS/Glaxo Wellcome collaboration modified

U.S. launch for prostate cancer imaging agent

Gen-Probe diagnostic approved by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...